NO159384C - Analogi-fremgangsmaate for fremstilling av terapeutisk aktive n6-(1-indanyl) adenosin-derivater. - Google Patents

Analogi-fremgangsmaate for fremstilling av terapeutisk aktive n6-(1-indanyl) adenosin-derivater.

Info

Publication number
NO159384C
NO159384C NO844830A NO844830A NO159384C NO 159384 C NO159384 C NO 159384C NO 844830 A NO844830 A NO 844830A NO 844830 A NO844830 A NO 844830A NO 159384 C NO159384 C NO 159384C
Authority
NO
Norway
Prior art keywords
indanyl
preparation
therapeutic active
analogy procedure
adenosin
Prior art date
Application number
NO844830A
Other languages
English (en)
Other versions
NO844830L (no
NO159384B (no
Inventor
Bharat Trivedi
Harriet Hamilton
Walter Moos
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO844830L publication Critical patent/NO844830L/no
Publication of NO159384B publication Critical patent/NO159384B/no
Publication of NO159384C publication Critical patent/NO159384C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO844830A 1983-12-05 1984-12-04 Analogi-fremgangsmaate for fremstilling av terapeutisk aktive n6-(1-indanyl) adenosin-derivater. NO159384C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/558,144 US4501735A (en) 1983-12-05 1983-12-05 N6-(1- and 2-benzocycloalkyl) adenosines

Publications (3)

Publication Number Publication Date
NO844830L NO844830L (no) 1985-06-06
NO159384B NO159384B (no) 1988-09-12
NO159384C true NO159384C (no) 1988-12-21

Family

ID=24228400

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844830A NO159384C (no) 1983-12-05 1984-12-04 Analogi-fremgangsmaate for fremstilling av terapeutisk aktive n6-(1-indanyl) adenosin-derivater.

Country Status (18)

Country Link
US (1) US4501735A (no)
EP (1) EP0144235A3 (no)
JP (1) JPS60136592A (no)
KR (1) KR850004484A (no)
AU (1) AU562690B2 (no)
CA (1) CA1230595A (no)
DK (1) DK573484A (no)
ES (1) ES538238A0 (no)
FI (1) FI77667C (no)
GR (1) GR81144B (no)
HU (1) HUT36482A (no)
IL (1) IL73700A (no)
NO (1) NO159384C (no)
NZ (1) NZ210428A (no)
OA (1) OA07883A (no)
PH (1) PH21367A (no)
PT (1) PT79613B (no)
ZA (1) ZA849337B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239397A (en) * 1983-08-01 1988-07-19 James A. Bristol N.sup.6-substituted adenosines
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
US4683223A (en) * 1985-09-09 1987-07-28 Warner-Lambert Company N6 -Benzopyrano-and benzothiopyrano adenosines and methods of use
AU577743B2 (en) * 1984-10-26 1988-09-29 Warner-Lambert Company N6-benzopyrano and benzothiopyrano adenosines
US4693996A (en) * 1985-12-23 1987-09-15 Warner-Lambert Company Method of treating heart failure and medicaments therefor
US4833273A (en) * 1986-02-03 1989-05-23 Warner-Lambert Company Process for the resolution of 1-aminoindanes
NZ222051A (en) * 1986-10-06 1990-07-26 Univ Virginia Solution containing adenosine or hypoxanthine and optionally ribose for heart protection during surgery
US5063233A (en) * 1986-11-14 1991-11-05 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
US4954504A (en) * 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
PT86660B (pt) * 1987-02-04 1992-02-28 Ciba Geigy Ag Processo para a preparacao de derivados de adenosina-5'-carboxamida
US4968697A (en) * 1987-02-04 1990-11-06 Ciba-Geigy Corporation 2-substituted adenosine 5'-carboxamides as antihypertensive agents
US4837207A (en) * 1987-05-13 1989-06-06 Warner-Lambert Company Diastereoisomers of n6 -endo-bicyclo[2.2.1]heptyladenosine as antihypertensives with selective action
US5410019A (en) * 1987-09-24 1995-04-25 The Administrators Of The Tulane-Educational Fund Therapeutic peptides
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH0725785B2 (ja) * 1989-01-11 1995-03-22 日本臓器製薬株式会社 アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
ATE147074T1 (de) * 1990-09-25 1997-01-15 Rhone Poulenc Rorer Int Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen
WO2000005234A1 (fr) * 1998-07-22 2000-02-03 Suntory Limited INHIBITEURS DE NF-λB CONTENANT DES DERIVES D'INDANE EN TANT QU'INGREDIENT ACTIF
JP2015172077A (ja) * 2015-06-24 2015-10-01 中国医学科学院葯物研究所 Ｎ６−置換アデノシン誘導体とｎ６−置換アデニン誘導体の鎮静、催眠、抗うつ、抗痙攣、抗てんかん、抗パーキンソン病と認知証予防・治療の用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670175A1 (de) * 1966-12-21 1970-11-05 Boehringer Mannheim Gmbh Verfahren zur Herstellung von Adenosin-Derivaten
DE1670265A1 (de) * 1967-08-25 1971-01-28 Boehringer Mannheim Gmbh 2-Amino-Adenosinderivate und Verfahren zu deren Herstellung
JPS4826038B1 (no) * 1970-09-25 1973-08-03
DE2059922A1 (de) * 1970-12-05 1972-06-15 Boehringer Mannheim Gmbh Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben
DE2136624A1 (de) * 1971-07-22 1973-02-08 Boehringer Mannheim Gmbh N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
US4090021A (en) * 1971-10-08 1978-05-16 Schering Aktiengesellschaft Process for the production of N6 -substituted adenosine nucleotides and products resulting therefrom
DE2230160A1 (de) * 1972-06-21 1974-01-31 Merck Patent Gmbh Adenosinderivat
US3922261A (en) * 1972-06-21 1975-11-25 Merck Patent Gmbh Adenosine derivative
JPS5046689A (no) * 1972-07-24 1975-04-25
DE2249397A1 (de) * 1972-10-09 1974-05-02 Merck Patent Gmbh Adenosinester und -aether
DE2406587A1 (de) * 1974-02-12 1975-08-21 Klinge Co Chem Pharm Fab Hypolipaemisch wirksame adenosinderivate
DE3019322A1 (de) * 1980-05-21 1981-12-03 Merck Patent Gmbh, 6100 Darmstadt Psychopharmakon sowie verwendung von adenosinderivaten
US4388308A (en) * 1980-06-09 1983-06-14 G.D. Searle & Co. N6 -[(2-Hydroxypropyl)aryl]adenosines
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten

Also Published As

Publication number Publication date
EP0144235A3 (en) 1986-07-30
OA07883A (en) 1986-11-20
ES8602033A1 (es) 1985-11-01
DK573484D0 (da) 1984-12-03
EP0144235A2 (en) 1985-06-12
US4501735A (en) 1985-02-26
HUT36482A (en) 1985-09-30
FI844750L (fi) 1985-06-06
CA1230595A (en) 1987-12-22
FI77667B (fi) 1988-12-30
JPS60136592A (ja) 1985-07-20
KR850004484A (ko) 1985-07-15
AU3621684A (en) 1985-06-13
PT79613B (en) 1986-12-12
DK573484A (da) 1985-06-06
PH21367A (en) 1987-10-15
GR81144B (en) 1985-04-04
FI77667C (fi) 1989-04-10
NO844830L (no) 1985-06-06
PT79613A (en) 1985-01-01
IL73700A0 (en) 1985-02-28
FI844750A0 (fi) 1984-12-03
NZ210428A (en) 1989-05-29
NO159384B (no) 1988-09-12
AU562690B2 (en) 1987-06-18
ES538238A0 (es) 1985-11-01
IL73700A (en) 1988-09-30
ZA849337B (en) 1986-07-30

Similar Documents

Publication Publication Date Title
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO163451C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO167384C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
NO159384C (no) Analogi-fremgangsmaate for fremstilling av terapeutisk aktive n6-(1-indanyl) adenosin-derivater.
NO164835C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO164301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO845176L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4h-3,1-benzoksazin-4-on-derivater
NO843084L (no) Fremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO171856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO164169C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO161738C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.